News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|November 26, 2021

Utilizing the 2021 evaluation and management coding update

Author(s)Miranda Hester

Contemporary Pediatrics sat down with Andrew J. Schuman, MD, FAAP, to discuss the nuances of the update.

The new evaluation and management (E/M) coding system for outpatient visits deployed by the Centers for Medicare & Medicaid Services was created to ease the burden of documentation for providers.

Contemporary Pediatrics sat down with Andrew J. Schuman, MD, FAAP, to discuss the nuances of the new system.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Practically expanding AI's role in infectious diseases, with Nicholas Marshall, MD, FAAP

Practically expanding AI's role in infectious diseases, with Nicholas Marshall, MD, FAAP

ByNicholas P. Marshall, MD, FAAP

October 21st 2025

Using ECGs to identify heart conditions in youth athletes, with Peace Madueme, MD | Image credit: Contemporary Pediatrics

Using ECGs to identify heart conditions in youth athletes, with Peace Madueme, MD

ByPeace Madueme, MD

October 16th 2025

Jeanne Marconi, MD, talks difficulties of implementing mental health screenings | Image credit: Contemporary Pediatrics

Jeanne Marconi, MD, talks difficulties of implementing mental health screenings

ByJeanne Marconi, MD

October 1st 2025

Physicians give AI scribes a thumbs-up!

ByJon Matthew Farber, MD,Marian Freedman

September 6th 2025

Lori Handy, MD: Vaccine-only visits can help ease back-to-school gaps | Image credit: CHOP

Lori Handy, MD: Vaccine-only visits can help ease back-to-school gaps

ByLori Handy, MD, MSCE

July 25th 2025

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Julie Khlevner, MD, AGAF, explains the impact of the FDA approval of linaclotide for pediatric IBS-C

Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD

Odevixibat demonstrates sustained pruritus and bile acid improvements in FIC1 deficiency

Linaclotide demonstrates positive long-term safety

Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children

© 2025 MJH Life Sciences^®

All rights reserved.